A prostate cancer tissue sample with low-grade (Gp3) and high-grade (Gp4) regions. Credit: Adam Sowalsky.

Low-grade prostate tumors can harbor signs of aggressive cancer

In a new study, Center for Cancer Research investigators found that low-grade and high-grade regions of prostate tumor tissue shared mutations typically linked to aggressive cancer. Testing for mutations to specific genes could help clinicians decide whether a patient with an initial low-grade result should undergo a follow-up biopsy. Learn more...

Chuan Wu joins CCR as a Stadtman tenure track investigator

Posted: Feb 27, 2017

Chuan Wu, M.D., Ph.D. has joined the Experimental Immunology Branch (EIB) as a Stadtman tenure track Investigator.  Dr. Wu's research focuses on differentiation of autoreactive T cells and the mechanism of neuro-immune crosstalk in autoimmunity.  Learn more...

Chuan Wu joins CCR as a Stadtman tenure track investigator

Conquer Cancer Foundation honors Farhad Fakhrejahani with a Genitourinary Cancers Symposium Merit Award

Posted: Feb 23, 2017

Farhad Fakhrejahani, M.D., Medical Oncology Fellow, has received a 2017 Conquer Cancer Foundation Merit Award. The award honors early career oncologists’ research activities and recognizes young scientists who have made a significant impact with their research. The award stipend assisted Dr. Fakhrejahani with presenting his research, "Avelumab in metastatic castration-resistant prostate cancer," at the Genitourinary Cancers Symposium in Orlando, Florida, which was held February 16-18.

Conquer Cancer Foundation honors Farhad Fakhrejahani with a Genitourinary Cancers Symposium Merit Award

Genome sequencing of Ewing sarcoma patients reveals genetic predisposition

Posted: Feb 23, 2017

The largest and most comprehensive genomic analysis of individuals with Ewing sarcoma performed to date reveals that some patients are genetically predisposed to developing the cancer.  Learn more...

Genome sequencing of Ewing sarcoma patients reveals genetic predisposition

Sandra Wolin joins CCR as Chief, RNA Biology Laboratory

Posted: Feb 21, 2017

Sandra Wolin, M.D., Ph.D., has joined CCR as the inaugural Chief of the newly established RNA Biology Laboratory on the Frederick campus. She will continue the world-class research program she established at Yale and will play a leading role in developing an integrated program in RNA biology in CCR. Learn more...

Sandra Wolin joins CCR as Chief, RNA Biology Laboratory

Terry Fry inducted into American Society of Clinical Investigation

Posted: Feb 14, 2017

Terry Fry, M.D., Investigator in the Pediatric Oncology Branch, is a newly elected member of The American Society for Clinical Investigation (ASCI), an honor society of physician-scientists who translate laboratory research to clinical practice. Dr. Fry's research is focused on the preclinical and clinical development of cell-based immunotherapy for pediatric leukemias. He is actively engaged in national cooperative groups involved in improving outcomes following hematopoietic stem cell transplantation for pediatric malignancies. More recently, his efforts have also focused on the use of genetically modified T cell therapy for acute lymphoblastic leukemia. He is one of 64 new members of the ASCI.  Learn more...

Terry Fry inducted into American Society of Clinical Investigation

Congressional members visit CCR

Posted: Feb 8, 2017

We were honored to welcome Rep. Tom Cole (R-OK) and members of the House Appropriations Committee, Labor and Health and Human Services (L-HHS) Subcommittee and provide them with a tour of our Molecular Imaging Program. Rep. Cole, Chairman of the L-HHS Subcommittee, was joined by Rep. Andrew Harris (R-MD), Rep. Jaime Herrera Beutler (R-WA), Rep. John Moolenaar (R-MI), Rep. Nita Lowey (D-NY), Rep. Rosa DeLauro (D-CT) and Rep. Barbara Lee (D-CA). 

Congressional members visit CCR

Steven Rosenberg featured on NBC's Today show

Posted: Feb 6, 2017

Steven Rosenberg, M.D., Ph.D., Chief of the Surgery Branch, was featured on NBC's Today Show on February 6. The segment featured Celine Ryan, one of Rosenberg's clinical trial patients with Stage IV colon cancer, who has been cancer-free for 10 months following her participation in an experimental gene therapy trial. "We can do, and are planning to do, that kind of gene therapy using the exact receptor we got from Celine's cells to treat other people," Rosenberg says. The treatment is not yet widely available, and it doesn't work for everyone, but "from every patient that we treat, whether their cancers go away or not, we learn something," he says. When patients hear they are cancer free, nothing compares to that feeling. Celine says: "NED. No evidence of disease. I love it and want it to continue forever. And I want other people to hear those words, too."  Learn more...

 

Steven Rosenberg featured on NBC's Today show

World Cancer Day

Posted: Feb 3, 2017

The Center for Cancer Research is marking World Cancer Day on February 4 with the five ways our research changes the world.  Learn more...

World Cancer Day

Registration now open for the 2017 NCI RNA Biology Symposium

Posted: Feb 2, 2017

RNA biology has emerged as one of the most influential areas in modern biology and biomedicine. This symposium offers you an opportunity to learn more about the current status of RNA biology in development and disease, share your research, network with leading figures in the field and discuss the use and implications of these advances for clinical applications.  Learn more...

Registration now open for the 2017 NCI RNA Biology Symposium

Dr. Zhengping Zhuang appointed as senior investigator

Posted: Jan 27, 2017

Zhengping Zhuang, M.D., Ph.D., has joined the Neuro-Oncology Branch (NOB) as a senior investigator.  Dr. Zhuang's research focuses on functional genomics and molecular signaling in central nervous system tumors to identify the critical genes and molecules in cancer formation and progression.  Learn more...

Dr. Zhengping Zhuang appointed as senior investigator

Pages